Doron Cohen
Director of Finance/CFO at GALMED PHARMACEUTICALS LTD.
Net worth: 69 $ as of 2024-03-30
Profile
Doron Cohen is currently the Chief Financial Officer at Galmed Pharmaceuticals Ltd.
and Onkai, Inc. He previously worked as the Chief Executive Officer at Tangram Strategic Ltd.
and as the Research Director at Gems Investment Research Ltd.
He also served as the Director-Public Relations at World Union of Jewish Students.
Mr. Cohen holds a graduate degree from Boston University and an undergraduate degree from The University of New South Wales.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-03-26 | 200 ( 0.01% ) | 69 $ | 2024-03-30 |
Doron Cohen active positions
Companies | Position | Start |
---|---|---|
GALMED PHARMACEUTICALS LTD. | Director of Finance/CFO | 2022-01-31 |
Onkai, Inc.
Onkai, Inc. Packaged SoftwareTechnology Services Onkai, Inc. develops a platform that helps local healthcare professionals. The private company is located in the US. | Director of Finance/CFO | 2023-09-30 |
Former positions of Doron Cohen
Companies | Position | End |
---|---|---|
Gems Investment Research Ltd. | Corporate Officer/Principal | 2016-12-31 |
Tangram Strategic Ltd. | Chief Executive Officer | - |
Training of Doron Cohen
Boston University | Graduate Degree |
The University of New South Wales | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
GALMED PHARMACEUTICALS LTD. | Health Technology |
Private companies | 3 |
---|---|
Onkai, Inc.
Onkai, Inc. Packaged SoftwareTechnology Services Onkai, Inc. develops a platform that helps local healthcare professionals. The private company is located in the US. | Technology Services |
Tangram Strategic Ltd. | |
Gems Investment Research Ltd. |
- Stock Market
- Insiders
- Doron Cohen